OpenAlex
PricingAboutJobs
Log inGet started
Work

Biomarkers Predicting Outcome in Patients with Advanced Renal Cell Carcinoma: Results from Sorafenib Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

HTML

Year: 2010
Type: article
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-09-3343
Authors: Carol Peña, Chetan Lathia, Minghua Shan, Bernard Escudier, Ronald M. Bukowski
Institutions: Cleveland Clinic, Institut Gustave Roussy
Language: English

Topic: Renal cell carcinoma treatment
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: advanced renal cell carcinoma, sorafenib, prognostic factors, treatment response biomarkers, vascular endothelial growth factor, soluble VEGFR-2, carbonic anhydrase IX, TIMP-1, p21ras, VHL mutation, plasma proteins, survival prediction, ECOG performance status, transarterial chemoembolization
SDG: Good health and well-being

Open Access status: closed

Funders: Bayer HealthCare, Onyx Pharmaceuticals
OpenAlex ID: W2135400147
FWCI: 10.28
Cites: 45
Cited by: 185
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms